Charlotte, NC, September 12, 2024 – We are pleased to showcase our involvement in the sale of Nivagen Pharmaceuticals’ MedisourceRx business unit, an FDA registered and inspected 503B outsourcing facility serving the wellness sector, to Hims & Hers, a leading health and wellness company. Nivagen specializes in the development, acquisition, and sale of generic prescription and over-the-counter products for the North American market, emphasizing high quality and affordability through global FDA-approved manufacturing partnerships. The proceeds from the sale will allow Nivagen to complete its state-of-the-art sterile injectables facility in California and launch its pipeline of sterile injectable ANDAs and 505(b)(2)s.

Engaged as the exclusive financial advisor to Nivagen, Bourne Partners provided critical counsel throughout the transaction, achieving a premium valuation for our client in an efficient process on an expeditious timeline.

We continue to be one of the most active advisers within the industry, having closed five transactions across compounding and sterile pharma manufacturing over the last 18 months. If you’re an operator or investor in this space considering an exit or a recapitalization mandate, please let us know. We are happy to share our expert perspective and advice on the current market, potential options, ideal timing, and best approach. Through the BourNetwork™ we also have a wide pool of global strategic acquirers and investor contacts seeking businesses across Pharma, Pharma Services, Consumer Health, and Healthcare Services.

Read the full press release here.

About Nivagen Pharmaceuticals

Nivagen Pharmaceuticals is a leading provider of high-quality generic and specialty pharmaceuticals in the United States. Headquartered in Sacramento, California, Nivagen is committed to delivering cost-effective healthcare solutions through the development, manufacturing, and distribution of generic medications that meet the highest industry standards. For more information, visit nivagen.com.

About MedisourceRx

MedisourceRx is an FDA Registered 503B Outsourcing Facility based in Los Alamitos, California. The company is a leader in customized sterile production for hospitals, surgery centers, and wellness clinics, across a variety of preparations and therapeutic areas. In addition, MedisourceRx is an experienced partner in the production of medications used in clinical trials. MedisourceRx operated as a subsidiary of Nivagen Pharmaceuticals. For more information, visit medisourcerx.com.

About Bourne Partners

Bourne Partners is a financial services firm specializing in the pharma, pharma services, OTC and consumer health sectors. Located in Charlotte, North Carolina, the company offers investment banking and advisory services. As owners and operators with over 20 years of experience, Bourne Partners strives to enrich the lives and improve the health and well-being of their partners and patients across the globe by facilitating the efficient movement of capital through the global healthcare sector. For more information, please visit here.

Source.